These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 25770923)

  • 21. Neutrophil-mediated tumour angiogenesis: subversion of immune responses to promote tumour growth.
    Tazzyman S; Niaz H; Murdoch C
    Semin Cancer Biol; 2013 Jun; 23(3):149-58. PubMed ID: 23410638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation.
    Maltby S; Khazaie K; McNagny KM
    Biochim Biophys Acta; 2009 Aug; 1796(1):19-26. PubMed ID: 19233249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monocyte/macrophage infiltration in tumors: modulators of angiogenesis.
    Dirkx AE; Oude Egbrink MG; Wagstaff J; Griffioen AW
    J Leukoc Biol; 2006 Dec; 80(6):1183-96. PubMed ID: 16997855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiogenic Properties of NK Cells in Cancer and Other Angiogenesis-Dependent Diseases.
    Radomska-Leśniewska DM; Białoszewska A; Kamiński P
    Cells; 2021 Jun; 10(7):. PubMed ID: 34209508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance.
    Allavena P; Sica A; Garlanda C; Mantovani A
    Immunol Rev; 2008 Apr; 222():155-61. PubMed ID: 18364000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy.
    Tartour E; Pere H; Maillere B; Terme M; Merillon N; Taieb J; Sandoval F; Quintin-Colonna F; Lacerda K; Karadimou A; Badoual C; Tedgui A; Fridman WH; Oudard S
    Cancer Metastasis Rev; 2011 Mar; 30(1):83-95. PubMed ID: 21249423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Angiogenesis and immune suppression: yin and yang of tumor progression?].
    Szala S
    Postepy Hig Med Dosw (Online); 2009 Dec; 63():598-612. PubMed ID: 20009124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myeloid cells functioning in tumor vascularization as a novel therapeutic target.
    McLean K; Buckanovich RJ
    Transl Res; 2008 Feb; 151(2):59-67. PubMed ID: 18201673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of myeloid cells in the promotion of tumour angiogenesis.
    Murdoch C; Muthana M; Coffelt SB; Lewis CE
    Nat Rev Cancer; 2008 Aug; 8(8):618-31. PubMed ID: 18633355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesis.
    Ferrara N
    Curr Opin Hematol; 2010 May; 17(3):219-24. PubMed ID: 20308892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-regulatory cells: key players in tumor immune escape and angiogenesis.
    Facciabene A; Motz GT; Coukos G
    Cancer Res; 2012 May; 72(9):2162-71. PubMed ID: 22549946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer CXC chemokine networks and tumour angiogenesis.
    Strieter RM; Burdick MD; Mestas J; Gomperts B; Keane MP; Belperio JA
    Eur J Cancer; 2006 Apr; 42(6):768-78. PubMed ID: 16510280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity.
    Verschuere T; Toelen J; Maes W; Poirier F; Boon L; Tousseyn T; Mathivet T; Gerhardt H; Mathieu V; Kiss R; Lefranc F; Van Gool SW; De Vleeschouwer S
    Int J Cancer; 2014 Feb; 134(4):873-84. PubMed ID: 23929302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myeloid-Derived Suppressor Cells and Proinflammatory Cytokines as Targets for Cancer Therapy.
    Atretkhany KN; Drutskaya MS
    Biochemistry (Mosc); 2016 Nov; 81(11):1274-1283. PubMed ID: 27914453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of tumor-associated macrophage in tumor progression.
    Fukuda K; Kobayashi A; Watabe K
    Front Biosci (Schol Ed); 2012 Jan; 4(2):787-98. PubMed ID: 22202090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myeloid cells in cancer-related inflammation.
    Caronni N; Savino B; Bonecchi R
    Immunobiology; 2015 Feb; 220(2):249-53. PubMed ID: 25454487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy?
    Apte RN; Voronov E
    Immunol Rev; 2008 Apr; 222():222-41. PubMed ID: 18364005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloid derived suppressor cells and their role in tolerance induction in cancer.
    Fujimura T; Mahnke K; Enk AH
    J Dermatol Sci; 2010 Jul; 59(1):1-6. PubMed ID: 20570112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evolving paradigm of cell-nonautonomous UPR-based regulation of immunity by cancer cells.
    Zanetti M; Rodvold JJ; Mahadevan NR
    Oncogene; 2016 Jan; 35(3):269-78. PubMed ID: 25893303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mast cell contribution to tumor angiogenesis: a clinical approach.
    Crivellato E; Nico B; Ribatti D
    Eur Cytokine Netw; 2009 Dec; 20(4):197-206. PubMed ID: 20167559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.